Bill Text: MI SCR0014 | 2019-2020 | 100th Legislature | Engrossed
Bill Title: A concurrent resolution to disapprove the proposed final action taken by the Certificate of Need Commission on the Certificate of Need (CON) Review Standards for Immune Effector Cell Therapy (IECT) Services.
Spectrum: Partisan Bill (Republican 17-0)
Status: (Passed) 2019-10-31 - Referred To Secretary For Record [SCR0014 Detail]
Download: Michigan-2019-SCR0014-Engrossed.html
As Adopted by
senate, October 30, 2019
THIS RESOLUTION IS OFFERED TO COMPLY WITH MCL 333.22215.
senate Concurrent Resolution No.14
Senators VanderWall, Shirkey, Bizon, Nesbitt, Theis, McBroom, Zorn, Lauwers, Bumstead, Horn, Stamas, LaSata, Outman, Victory, MacDonald and Daley offered the following concurrent resolution:
Whereas, The Certificate of Need Commission voted on September 19, 2019, to approve a proposed final action on the Certificate of Need (CON) Review Standards for Immune Effector Cell Therapy (IECT) Services. The standards would require providers to receive state approval and third-party accreditation to deliver IECT services to Michigan patients. The proposed final action was submitted on September 24, 2019 to the joint legislative committee established by MCL 333.22219; and
Whereas, Pursuant to MCL 333.22215, the Legislature may disapprove a proposed final action of the CON Commission within 45 days after the date of submission to the members of the joint legislative committee. Legislative disapproval shall be expressed by concurrent resolution adopted by each house of the Legislature. A proposed final action by the CON Commission to develop, approve, disapprove, or revise CON review standards for the initiation, replacement, or expansion of covered clinical services is not effective if it has been disapproved; and
Whereas, The Certificate of Need (CON) Review Standards for Immune Effector Cell Therapy (IECT) Services would limit patient access to innovative, new cancer treatments. Through their review and approval process, the U.S. Food and Drug Administration already requires comprehensive safety criteria and standards for facilities providing cell therapies. It is unnecessary to require additional onerous and costly approvals and accreditations on facilities that go beyond federal government requirements. Additional requirements may discourage or prevent sites from providing IECT services in Michigan; now, therefore, be it
Resolved by the Senate (the House of Representatives concurring), That we disapprove the proposed final action taken on the Certificate of Need (CON) Review Standards for Immune Effector Cell Therapy (IECT) Services by the Certificate of Need Commission on September 19, 2019; and be it further
Resolved, That copies of this resolution be transmitted to the Governor, the Director of the Michigan Department of Health and Human Services, and the Chairperson of the Certificate of Need Commission.
